Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 28;12(7):2558.
doi: 10.3390/jcm12072558.

Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review

Sofia D Shaikh  1 , Natalie Sun  1 , Andrew Canakis  2 , William Y Park  3 , Horst Christian Weber  4   5
Affiliations
Review

Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review

Sofia D Shaikh et al. J Clin Med. .

Abstract

Irritable Bowel Syndrome (IBS) is a functional disorder of the gastrointestinal tract characterized by abdominal pain and altered bowel habits. It has a prevalence of 10 to 25% in the United States and has a high disease burden, as evidenced by reduced quality of life, decreased work productivity and increased healthcare utilization and costs. IBS has been associated with several intra-intestinal and extra-intestinal conditions, including psychiatric comorbidities. Although the pathophysiology of IBS has not been fully elucidated, it involves dysregulation of communication between the brain and gut (brain-gut axis) which is associated with alterations in intestinal motility, gut permeability, visceral hypersensitivity and gut microbiota composition. The purpose of this article is to review the role the gut microbiota plays in the pathophysiology of IBS, understand factors that affect the gut microbiome and explore the microbiome as a target of treatment.

Keywords: FODMAP diet; brain gut axis; fecal microbiota transplantation; gut microbiome; irritable bowel syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Elements in the Pathophysiology of Irritable Bowel Syndrome.
See this image and copyright information in PMC

References

    1. Sperber A.D., Dumitrascu D., Fukudo S., Gerson C., Ghoshal U.C., Gwee K.A., Hungin A.P.S., Kang J.Y., Minhu C., Schmulson M., et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: A Rome Foundation working team literature review. Gut. 2017;66:1075–1082. doi: 10.1136/gutjnl-2015-311240. - DOI - PubMed
    1. Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014;6:71–80. - PMC - PubMed
    1. Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J., Whitehead W.E., Dumitrascu D.L., Fang X., Fukudo S., et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160:99–114.e3. doi: 10.1053/j.gastro.2020.04.014. - DOI - PubMed
    1. Lovell R.M., Ford A.C. Effect of gender on prevalence of irritable bowel syndrome in the community: Systematic review and meta-analysis. Am. J. Gastroenterol. 2012;107:991–1000. doi: 10.1038/ajg.2012.131. - DOI - PubMed
    1. Lacy B., Patel N. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J. Clin. Med. 2017;6:99. doi: 10.3390/jcm6110099. - DOI - PMC - PubMed

LinkOut - more resources